Levin Capital Strategies L.P. decreased its holdings in shares of Cigna Group (NYSE:CI – Free Report) by 49.4% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,070 shares of the health services provider’s stock after selling 3,000 shares during the quarter. Levin Capital Strategies L.P.’s holdings in Cigna Group were worth $845,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds and other institutional investors have also made changes to their positions in CI. Capital Research Global Investors lifted its holdings in shares of Cigna Group by 140.2% during the 3rd quarter. Capital Research Global Investors now owns 3,179,301 shares of the health services provider’s stock valued at $916,434,000 after acquiring an additional 1,855,897 shares in the last quarter. Massachusetts Financial Services Co. MA increased its stake in Cigna Group by 8.3% during the 4th quarter. Massachusetts Financial Services Co. MA now owns 11,805,083 shares of the health services provider’s stock worth $3,249,113,000 after buying an additional 903,334 shares during the period. Ameriprise Financial Inc. increased its stake in Cigna Group by 54.5% during the 3rd quarter. Ameriprise Financial Inc. now owns 2,136,311 shares of the health services provider’s stock worth $615,781,000 after buying an additional 753,865 shares during the period. M&T Bank Corp increased its stake in Cigna Group by 1,299.3% during the 4th quarter. M&T Bank Corp now owns 635,706 shares of the health services provider’s stock worth $174,965,000 after buying an additional 590,277 shares during the period. Finally, Vanguard Group Inc. increased its stake in Cigna Group by 1.6% during the 4th quarter. Vanguard Group Inc. now owns 26,173,577 shares of the health services provider’s stock worth $7,203,754,000 after buying an additional 414,834 shares during the period. Institutional investors and hedge funds own 86.99% of the company’s stock.
Cigna Group Trading Up 2.5%
NYSE CI opened at $292.16 on Thursday. Cigna Group has a one year low of $239.51 and a one year high of $350.00. The company has a 50-day simple moving average of $274.24 and a 200-day simple moving average of $276.84. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.74 and a current ratio of 0.74. The firm has a market capitalization of $76.99 billion, a PE ratio of 13.17, a price-to-earnings-growth ratio of 0.98 and a beta of 0.26.
Cigna Group Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Thursday, June 18th. Shareholders of record on Thursday, June 4th will be paid a dividend of $1.56 per share. This represents a $6.24 dividend on an annualized basis and a yield of 2.1%. The ex-dividend date of this dividend is Thursday, June 4th. Cigna Group’s payout ratio is presently 28.13%.
Wall Street Analyst Weigh In
Several equities research analysts recently issued reports on CI shares. Guggenheim reaffirmed a “buy” rating and set a $318.00 price target on shares of Cigna Group in a research note on Monday, February 2nd. Leerink Partners lifted their price target on shares of Cigna Group from $270.00 to $297.00 and gave the stock a “market perform” rating in a research note on Friday, February 6th. Sanford C. Bernstein raised shares of Cigna Group from a “market perform” rating to an “outperform” rating and lifted their price target for the stock from $307.00 to $358.00 in a research note on Thursday, March 12th. Zacks Research raised shares of Cigna Group from a “strong sell” rating to a “hold” rating in a research note on Monday, January 5th. Finally, Piper Sandler dropped their price target on shares of Cigna Group from $374.00 to $370.00 and set an “overweight” rating on the stock in a research note on Tuesday, March 3rd. One analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and four have given a Hold rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $332.47.
Get Our Latest Research Report on CI
Insider Transactions at Cigna Group
In other Cigna Group news, insider Nicole S. Jones sold 2,307 shares of the business’s stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $666,515.37. Following the completion of the transaction, the insider directly owned 32,647 shares of the company’s stock, valued at $9,432,044.77. The trade was a 6.60% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Everett Neville sold 1,719 shares of the business’s stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $496,636.29. Following the transaction, the insider directly owned 5,670 shares of the company’s stock, valued at $1,638,119.70. The trade was a 23.26% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders own 0.60% of the company’s stock.
About Cigna Group
Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.
In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.
Read More
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI – Free Report).
Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.
